Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
- PMID: 10835641
- DOI: 10.1038/76095
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
Abstract
Gene-transfer vectors based on lentiviruses are distinguished by their ability to transduce non-dividing cells. The HIV-1 proteins Matrix, Vpr and Integrase have been implicated in the nuclear import of the viral genome in non-dividing cells. Here we show that a sequence within pol is also required in cis. It contains structural elements previously associated with the progress of reverse transcription in target cells. We restored these elements in cis within late-generation lentiviral vectors. The new vector transduced to a much higher efficiency several types of human primary cells, when both growing and growth-arrested, including haematopoietic stem cells assayed by long-term repopulation of NOD/SCID mice. On in vivo administration into SCID mice, the vector induced higher plasma levels of human clotting factor IX (F.IX) than non-modified vector. Our results indicate that nuclear translocation of the genome is a rate-limiting step in lentiviral infection of both dividing and non-dividing cells, and that it depends on protein and nucleic acid sequence determinants. Full rescue of this step in lentivirus-based vectors improves performance for gene-therapy applications.
Similar articles
-
The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.Blood. 2000 Dec 15;96(13):4103-10. Blood. 2000. PMID: 11110680
-
Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo.Mol Ther. 2001 Sep;4(3):164-73. doi: 10.1006/mthe.2001.0450. Mol Ther. 2001. PMID: 11545606
-
Production of lentiviral vectors for transducing cells from the central nervous system.J Vis Exp. 2012 May 24;(63):e4031. doi: 10.3791/4031. J Vis Exp. 2012. PMID: 22664962 Free PMC article.
-
HIV-1 vector systems.Somat Cell Mol Genet. 2001 Nov;26(1-6):51-81. doi: 10.1023/a:1021074613196. Somat Cell Mol Genet. 2001. PMID: 12465462 Review.
-
Lentiviral vectors for gene therapy of HIV-1 infection.Curr Gene Ther. 2002 Feb;2(1):23-43. doi: 10.2174/1566523023348165. Curr Gene Ther. 2002. PMID: 12108972 Review.
Cited by
-
Luciferase transduction and selection protocol for reliable in vivo bioluminescent measurements in cancer research.Heliyon. 2024 Jun 23;10(13):e33356. doi: 10.1016/j.heliyon.2024.e33356. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39035528 Free PMC article.
-
Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity.Cell Rep Med. 2024 Jul 16;5(7):101640. doi: 10.1016/j.xcrm.2024.101640. Epub 2024 Jul 2. Cell Rep Med. 2024. PMID: 38959885 Free PMC article.
-
Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia.JCI Insight. 2024 May 22;9(10):e171650. doi: 10.1172/jci.insight.171650. JCI Insight. 2024. PMID: 38775150 Free PMC article.
-
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma.EMBO Mol Med. 2024 Jun;16(6):1324-1351. doi: 10.1038/s44321-024-00077-3. Epub 2024 May 10. EMBO Mol Med. 2024. PMID: 38730056 Free PMC article.
-
PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.EMBO J. 2024 Mar;43(6):1015-1042. doi: 10.1038/s44318-024-00043-2. Epub 2024 Feb 15. EMBO J. 2024. PMID: 38360994 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical